Vaccination with autologous dendritic cells: From experimental autoimmune encephalomyelitis to multiple sclerosis

Journal of Neuroimmunology

Volumn 114, Issue 1-2, 2001, Pages 1-7

  Link, Hans ^a   Huang, Yu Min ^a   Masterman, Thomas ^a   Xiao, Bao Guo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dendritic cells; Experimental autoimmune encephalomyelitis; Immunotherapy; Multiple sclerosis; Tolerance; Vaccination

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL FUNCTION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MOLECULAR BIOLOGY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VACCINATION;

ANIMALS; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTHERAPY, ACTIVE; MULTIPLE SCLEROSIS;

EID: 0035283235     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00247-8     Document Type: Review

References (58)

1. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
2. Dendritic cells and the control of immunity
3. Immunobiology of dendritic cells
4. Interferon-beta inhibits Th1 responses at the dendritic cell. Relevance to multiple sclerosis
5. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis
6. Dendritic cells
7. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression
8. Survival of mature CD4+ T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells
9. The role of dendritic cells in T cell selection and survival
10. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer
11. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis
12. Nitrergic mechanism of DC-mediated T-cell elimination
13. How can dendritic cells cause autoimmune disease?
14. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
15. Dendritic cells: Unique leukocyte populations which control the primary immune response
16. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines
17. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis in Lewis rats
18. Altered phenotype and function of dendritic cells in multiple sclerosis is modified by IL-10 and IFN-β: A novel mechanism of immunomodulation applicable to therapy?
19. Interferon-beta induces the development of type 2 dendritic cells
20. Freshly isolated Peter's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
21. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
22. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
23. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat
24. Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis
25. Induction of Th2 cell differentiation in the primary immune response: Dendritic cells isolated from adherent cell culture treated with IL-10 prime naïve CD4+ T cells to secrete IL-4
26. TH2-inducing DC2 for immunotherapy
27. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: Nitric oxide production is associated with dendritic cell apoptosis
28. Dendritic cells produce IL-12 and direct the development of Th1 cells from naïve CD4+ T cells
29. CD8α+ and CD8α- subclasses of dendritic cells direct the development of distinct T helper cells in vivo
30. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells
31. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells
32. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
33. Role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells
34. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity II. Epidermal Langerhans cells and peritoneal exudate macrophages
35. The role of dendritic cells in T cell activation
36. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells
37. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
38. Reciprocal control of T helper cell and dendritic cell differentiation
39. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines
40. Dendritic cells are adjuvants for immune-mediated resistance to tumours
41. Transfer of dendritic cells vivo stimulated with interferon-gamma down-modulates autoimmune diabetes in non-obese diabetic mice
42. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells
43. Induction of tolerance by IL-10-treated dendritic cells
44. Interleukin-10-treated dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells
45. Dendritic cells and tolerance induction
46. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type responses and require obligatory cytokine signals for induction of Th1 immunity
47. A subclass of dendritic cells kills CD4 T cells via Fas-FasL induced apoptosis
48. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis
49. When engineered to produce TGF-β1, antigen specific T cells down regulate Th1 cell-mediated autoimmune and Th2 cell-mediated allergic inflammatory processes
50. Myelin antigen-pulsed splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism
51. Expanding dendritic cells in vivo enhances the induction of oral tolerance
52. Pathological changes in the islet milieu precede infiltration of islets and destruction of β-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM
53. Modulating dendritic cells to optimize mucosal immunization protocols
54. Researchers and regulators reflect on first gene therapy death
55. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
56. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: A role for dendritic cells in inducing apoptosis of CD4+ T cells
57. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis in Lewis rats
58. Adherent dendritic cells expressing high levels of IL-10 and low levels of IL-12 induce antigen-specific tolerance to experimental allergic encephalomyelitis